Preventable Hospitalizations and Kidney Care

可预防的住院治疗和肾脏护理

阅读:1

Abstract

Among individuals with kidney disease hospitalization rates are up to 38% higher than the general population, increase proportionally with each stage of CKD, and significantly contribute to over $130 billion in annual care costs in the United States (US). Many hospitalizations, including readmissions, are potentially preventable, and their avoidance could substantially lessen the burden and cost of kidney disease. Across the spectrum of types of kidney disease, shared drivers of preventable hospitalizations include clinical complexity and difficulty with self-management at the patient level; clinical inertia, under-recognition of kidney disease, and lack of awareness of guidelines at the provider level; and fragmented care and underinvestment in supportive strategies for individuals with social needs at the system level. The mechanisms by which these drivers lead to preventable hospitalizations, however, differ by the categories of kidney disease. Although community-acquired AKI, because of environmental exposures and infectious disease, frequently leads to incident hospitalization, hospital-acquired AKI raises the risk of readmission after index hospitalization for another cause. Among individuals with CKD, complex comorbidities, polypharmacy, and barriers to timely and coordinated ambulatory care lead to emergency department visits for ambulatory care needs at which point admissions occur at higher rates than the general population. Among individuals with kidney failure, preventable hospitalizations are most commonly related to fluid overload, dialysis access dysfunction, and infections. Accessible and timely ambulatory care combined with multidisciplinary collaboration, postdischarge transitional care programs to prevent readmissions, and support for patient self-management are strategies to reduce the rate of preventable hospitalizations. In this article, we review the drivers of preventable hospitalizations for AKI, CKD, and dialysis-dependent kidney failure. We also explore the evidence for multi-level models of care that target risks of preventable hospitalizations and readmissions, and federal programs that financially incentivize such models.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。